Skip to main content

Table 2 Number of samples per cancer type in the present analysis

From: Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs

TCGA code Cancer type Number of samples
BLCA Bladder urothelial carcinoma 127
BRCA Breast invasive carcinoma 877
COAD Colon adenocarcinoma 380
GBM Glioblastoma multiforme 456
HNSC Head and neck squamous cell carcinoma 294
KIRC Kidney renal clear cell carcinoma 433
LAML Acute myeloid leukemia 153
LUAD Lung adenocarcinoma 305
LUSC Lung squamous cell carcinoma 241
OV Ovarian serous cystadenocarcinoma 512
PRAD Prostate adenocarcinoma 325
SKCM Skin cutaneous melanoma 244
STAD Stomach adenocarcinoma 163
THCA Thyroid carcinoma 438
UCEC Uterine corpus endometrial carcinoma 423